Delving into the Latest Updates on Jiangsu Better Time Biotechnology Co., Ltd with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Immune System Diseases

Other Diseases

Biological products

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Unknown	2
Biological products	1
Small molecule drug	1

Top 5 Target	Count

CD44(CD44 antigen)	1

[Translation] Evaluation of the efficacy and safety of cross-linked sodium hyaluronate injection BTM002 compared with Aldrin in the treatment of patients with knee osteoarthritis pain who are unresponsive to non-drug and general analgesics: a multicenter, randomized, double-blind, parallel, positive-controlled phase III clinical study

· 主要研究目的：以阿尔治（Artz）为对照（1周1次，共5次），评价交联玻璃酸钠注射液BTM002单次给药治疗保守性非药物治疗及一般镇痛剂治疗无效的膝骨关节炎疼痛患者的有效性； · 次要研究目的：以阿尔治（Artz）为对照（1周1次，共5次），评价交联玻璃酸钠注射液BTM002单次给药治疗保守性非药物治疗及一般镇痛剂治疗无效的膝骨关节炎疼痛患者的安全性。

[Translation]

· Primary study purpose: Using Artz as a control (once a week, 5 times in total), evaluate the effectiveness of a single dose of cross-linked sodium hyaluronate injection BTM002 in treating patients with knee osteoarthritis pain who have failed conservative non-drug treatment and general analgesics; · Secondary study purpose: Using Artz as a control (once a week, 5 times in total), evaluate the safety of a single dose of cross-linked sodium hyaluronate injection BTM002 in treating patients with knee osteoarthritis pain who have failed conservative non-drug treatment and general analgesics.

Start Date-

Sponsor / Collaborator

SciVision Biotech, Inc.

[+1]

100 Clinical Results associated with Jiangsu Better Time Biotechnology Co., Ltd

Login to view more data

0 Patents (Medical) associated with Jiangsu Better Time Biotechnology Co., Ltd

Login to view more data

100 Deals associated with Jiangsu Better Time Biotechnology Co., Ltd

Login to view more data

100 Translational Medicine associated with Jiangsu Better Time Biotechnology Co., Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

3

1

Phase 3

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Cross-linked Sodium Hyaluronate ( CD44 )	Osteoarthritis, Knee More	Phase 3
BTM001	Osteoarthritis, Knee More	Preclinical
BTM003	Cystitis, Interstitial More	Preclinical
BTM-101	Localized obesity More	Preclinical